FR2970967B1 - Derives de type azaindazole ou diazaindazole comme medicament - Google Patents
Derives de type azaindazole ou diazaindazole comme medicamentInfo
- Publication number
- FR2970967B1 FR2970967B1 FR1150651A FR1150651A FR2970967B1 FR 2970967 B1 FR2970967 B1 FR 2970967B1 FR 1150651 A FR1150651 A FR 1150651A FR 1150651 A FR1150651 A FR 1150651A FR 2970967 B1 FR2970967 B1 FR 2970967B1
- Authority
- FR
- France
- Prior art keywords
- diazaindazole
- azaindazole
- derivatives
- medicinal product
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VQNDBXJTIJKJPV-UHFFFAOYSA-N 2h-triazolo[4,5-b]pyridine Chemical class C1=CC=NC2=NNN=C21 VQNDBXJTIJKJPV-UHFFFAOYSA-N 0.000 title 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Priority Applications (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1150651A FR2970967B1 (fr) | 2011-01-27 | 2011-01-27 | Derives de type azaindazole ou diazaindazole comme medicament |
TW101102531A TWI546303B (zh) | 2011-01-27 | 2012-01-20 | 氮雜吲唑(azaindazole)或二氮雜吲唑(diazaindazole)類型之衍生物供作藥物之用途 |
HUE12701884A HUE037153T2 (hu) | 2011-01-27 | 2012-01-27 | Azaindazol vagy diazaindazol típusú származékok mint gyógyszerek |
AU2012210467A AU2012210467B2 (en) | 2011-01-27 | 2012-01-27 | Derivatives of azaindazole or diazaindazole type as medicament |
SI201231273T SI2668184T1 (en) | 2011-01-27 | 2012-01-27 | PRODUCTS OF AZAINDAZOL OR DIAZAINDAZOL AS A MEDICINAL PRODUCT |
UAA201310425A UA109698C2 (xx) | 2011-01-27 | 2012-01-27 | Похідні азаіндазолу або діазаіндазолу як медикамент |
KR1020187031264A KR20180122028A (ko) | 2011-01-27 | 2012-01-27 | 의약으로서의 아자인다졸 또는 디아자인다졸 유형의 유도체 |
CN201280006671.8A CN103339129B (zh) | 2011-01-27 | 2012-01-27 | 作为药物的氮杂吲唑或二氮杂吲唑类衍生物 |
TR2018/02944T TR201802944T4 (tr) | 2011-01-27 | 2012-01-27 | İlaç olarak azai̇ndazol veya di̇azai̇ndazol türünün türevleri̇ |
RU2013138624/04A RU2600976C2 (ru) | 2011-01-27 | 2012-01-27 | Производные азаиндазола или диазаиндазола в качестве медикамента |
ARP120100272A AR084935A1 (es) | 2011-01-27 | 2012-01-27 | Derivados de tipo azaindazol o diazaindazol como medicamentos |
MX2013008673A MX356411B (es) | 2011-01-27 | 2012-01-27 | Derivados del tipo del azaindazol o diazaindazol como medicamento. |
DK12701884.4T DK2668184T3 (en) | 2011-01-27 | 2012-01-27 | DERIVATIVES OF AZAINDAZOL OR DIAZAINDAZOL TYPE AS MEDICATION |
EP12701884.4A EP2668184B1 (fr) | 2011-01-27 | 2012-01-27 | Dérivés de type azaindazole ou diazaindazole utilisés comme médicaments |
PT127018844T PT2668184T (pt) | 2011-01-27 | 2012-01-27 | Derivados do tipo azaindazole ou diazaindazole utilizados como medicamentos |
US13/823,658 US20130172360A1 (en) | 2011-01-27 | 2012-01-27 | Derivatives of azaindazole or diazaindazole type as medicament |
RS20180418A RS57101B1 (sr) | 2011-01-27 | 2012-01-27 | Derivati tipa azaindazola ili diazaindazola kao lek |
MA36177A MA34903B1 (fr) | 2011-01-27 | 2012-01-27 | Derives de type azaindazole ou diazaindazole utilises comme medicaments |
PL12701884T PL2668184T3 (pl) | 2011-01-27 | 2012-01-27 | Pochodne typu azaindazolu lub diazaindazolu jako lek |
MYPI2013002799A MY180666A (en) | 2011-01-27 | 2012-01-27 | Substituted pyrazolo [3,4-b] pyridines as medicaments |
CA2823824A CA2823824C (fr) | 2011-01-27 | 2012-01-27 | Derives d'azaindazoles et de diazaindazoles et leur utilisation comme medicaments |
JP2013550886A JP5931926B2 (ja) | 2011-01-27 | 2012-01-27 | 医薬としてのアザインダゾールまたはジアザインダゾール型の誘導体 |
NZ614432A NZ614432B2 (en) | 2011-01-27 | 2012-01-27 | Derivatives of azaindazole or diazaindazole type as medicament |
ES12701884.4T ES2661695T3 (es) | 2011-01-27 | 2012-01-27 | Derivados de tipo azaindazol o diazaindazol como medicamento |
KR1020137022330A KR101923751B1 (ko) | 2011-01-27 | 2012-01-27 | 의약으로서의 아자인다졸 또는 디아자인다졸 유형의 유도체 |
PCT/EP2012/051283 WO2012101239A1 (fr) | 2011-01-27 | 2012-01-27 | Dérivés de type azaindazole ou diazaindazole utilisés comme médicaments |
LTEP12701884.4T LT2668184T (lt) | 2011-01-27 | 2012-01-27 | Azaindazolo arba diazaindazolo tipo dariniai kaip vaistai |
US13/686,334 US8883821B2 (en) | 2011-01-27 | 2012-11-27 | Substituted pyrazolo[3,4-b]pyridines as medicaments |
TNP2013000293A TN2013000293A1 (en) | 2011-01-27 | 2013-07-11 | Derivatives of azaindazole or diazaindazole type as medicament |
IL227496A IL227496B (en) | 2011-01-27 | 2013-07-16 | Pyrazolo[4,3–b]pyridines are converted as drugs |
HK13114261.8A HK1186737A1 (en) | 2011-01-27 | 2013-12-24 | Derivatives of azaindazole or diazaindazole type as medicament |
IL257748A IL257748B (en) | 2011-01-27 | 2018-02-26 | Derivatives of pyrazole [4,3-b]pyridine, pyrazolo[4,3-b]pyridine and pyrazolo[4,3-b]pyrazine for use in the treatment of cancer, inflammatory diseases and neurodegenerative diseases, |
CY20181100338T CY1120088T1 (el) | 2011-01-27 | 2018-03-26 | Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου ως φαρμακo |
HRP20180524TT HRP20180524T1 (hr) | 2011-01-27 | 2018-03-29 | Derivati tipa azaindazola ili diazaindazola kao lijek |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1150651A FR2970967B1 (fr) | 2011-01-27 | 2011-01-27 | Derives de type azaindazole ou diazaindazole comme medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2970967A1 FR2970967A1 (fr) | 2012-08-03 |
FR2970967B1 true FR2970967B1 (fr) | 2013-02-15 |
Family
ID=44318089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1150651A Active FR2970967B1 (fr) | 2011-01-27 | 2011-01-27 | Derives de type azaindazole ou diazaindazole comme medicament |
Country Status (30)
Country | Link |
---|---|
US (2) | US20130172360A1 (fr) |
EP (1) | EP2668184B1 (fr) |
JP (1) | JP5931926B2 (fr) |
KR (2) | KR20180122028A (fr) |
CN (1) | CN103339129B (fr) |
AR (1) | AR084935A1 (fr) |
AU (1) | AU2012210467B2 (fr) |
CA (1) | CA2823824C (fr) |
CY (1) | CY1120088T1 (fr) |
DK (1) | DK2668184T3 (fr) |
ES (1) | ES2661695T3 (fr) |
FR (1) | FR2970967B1 (fr) |
HK (1) | HK1186737A1 (fr) |
HR (1) | HRP20180524T1 (fr) |
HU (1) | HUE037153T2 (fr) |
IL (2) | IL227496B (fr) |
LT (1) | LT2668184T (fr) |
MA (1) | MA34903B1 (fr) |
MX (1) | MX356411B (fr) |
MY (1) | MY180666A (fr) |
PL (1) | PL2668184T3 (fr) |
PT (1) | PT2668184T (fr) |
RS (1) | RS57101B1 (fr) |
RU (1) | RU2600976C2 (fr) |
SI (1) | SI2668184T1 (fr) |
TN (1) | TN2013000293A1 (fr) |
TR (1) | TR201802944T4 (fr) |
TW (1) | TWI546303B (fr) |
UA (1) | UA109698C2 (fr) |
WO (1) | WO2012101239A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
FR2970967B1 (fr) * | 2011-01-27 | 2013-02-15 | Pf Medicament | Derives de type azaindazole ou diazaindazole comme medicament |
US9458147B2 (en) | 2012-02-22 | 2016-10-04 | Sanford-Burnham Medical Research Institute | Sulfonamide compounds and uses as TNAP inhibitors |
HUE042374T2 (hu) | 2012-06-13 | 2019-06-28 | Incyte Holdings Corp | Szubsztituált triciklusos vegyületek mint FGFR inhibitorok |
EP2689779A1 (fr) * | 2012-07-27 | 2014-01-29 | Pierre Fabre Medicament | Dérivés de type azaindazole ou diazaindazole pour traiter un cancer surexprimant la trk |
EP2689778A1 (fr) * | 2012-07-27 | 2014-01-29 | Pierre Fabre Medicament | Dérivés de type azaindazole ou diazaindazole pour le traitement de la douleur |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
EA035095B1 (ru) | 2013-04-19 | 2020-04-27 | Инсайт Холдингс Корпорейшн | Бициклические гетероциклы в качестве ингибиторов fgfr |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
WO2016096709A1 (fr) | 2014-12-16 | 2016-06-23 | Eudendron S.R.L. | Dérivés hétérocycliques modulant l'activité de certaines protéines kinases |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
CN113004278B (zh) | 2015-02-20 | 2023-07-21 | 因赛特控股公司 | 作为fgfr抑制剂的双环杂环 |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10211205B2 (en) * | 2016-04-27 | 2019-02-19 | International Business Machines Corporation | Field effect transistor structure for reducing contact resistance |
CN108570052A (zh) * | 2017-03-13 | 2018-09-25 | 中国科学院上海药物研究所 | 五元杂环并吡嗪化合物、制备方法、中间体、组合和应用 |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
AU2019262195A1 (en) | 2018-05-04 | 2020-12-24 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
AU2019262579A1 (en) | 2018-05-04 | 2020-12-24 | Incyte Corporation | Salts of an FGFR inhibitor |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
EP3725777A1 (fr) * | 2019-04-17 | 2020-10-21 | Rottapharm Biotech S.r.l. | Benzo- et pyrido-pyrazoles en tant qu`inhibiteurs de protéine kinase |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
BR112022007163A2 (pt) | 2019-10-14 | 2022-08-23 | Incyte Corp | Heterociclos bicíclicos como inibidores de fgfr |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
CN115916771A (zh) * | 2020-04-02 | 2023-04-04 | 浙江华海药业股份有限公司 | 多靶点的抗肿瘤化合物及其制备方法和应用 |
AU2021382360A1 (en) | 2020-11-20 | 2023-06-22 | 2692372 Ontario, Inc. | Benzenesulfonamide derivatives and uses thereof |
CA3220274A1 (fr) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0001507A3 (en) * | 1997-03-19 | 2002-01-28 | Abbott Gmbh & Co Kg | Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
EP1215208B1 (fr) | 1997-10-27 | 2006-07-12 | Agouron Pharmaceuticals, Inc. | Dérivées de 4-aminothiazole, leur préparation et leur utilisation comme inhibiteurs des kinases cycline-depenents |
DE60104691T2 (de) | 2000-06-22 | 2005-01-13 | Pfizer Inc. | Verfahren zur herstellung von pyrazolopyrimidinonen |
AU2003245700A1 (en) * | 2002-02-12 | 2003-09-04 | Glaxo Group Limited | Pyrazolopyridine derivatives |
DE102004061288A1 (de) * | 2004-12-14 | 2006-06-29 | Schering Ag | 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel |
EP1919913A2 (fr) * | 2005-08-25 | 2008-05-14 | F.Hoffmann-La Roche Ag | Inhibiteurs de la map-kinase p38 et ses methodes d'utilisation |
CA2657287A1 (fr) | 2006-07-17 | 2008-01-24 | Merck & Co., Inc. | Composes de 1-hydroxy naphtyridine en tant qu'agents anti-vih |
BRPI0720589A2 (pt) | 2006-12-20 | 2014-02-25 | Nerviano Medical Sciences Srl | Derivados de indazol como inibidores da quinase para tratamento do câncer, derivados de indazol como inibidores da quinase para tratamento do câncer |
DK2176231T3 (en) | 2007-07-20 | 2016-12-12 | Nerviano Medical Sciences Srl | SUBSTITUTED indazole ACTIVE AS kinase inhibitors |
WO2010069966A1 (fr) | 2008-12-18 | 2010-06-24 | Nerviano Medical Sciences S.R.L. | Dérivés d'indazole substitués actifs en tant qu'inhibiteurs de kinases |
FR2970967B1 (fr) * | 2011-01-27 | 2013-02-15 | Pf Medicament | Derives de type azaindazole ou diazaindazole comme medicament |
-
2011
- 2011-01-27 FR FR1150651A patent/FR2970967B1/fr active Active
-
2012
- 2012-01-20 TW TW101102531A patent/TWI546303B/zh active
- 2012-01-27 CN CN201280006671.8A patent/CN103339129B/zh active Active
- 2012-01-27 MY MYPI2013002799A patent/MY180666A/en unknown
- 2012-01-27 LT LTEP12701884.4T patent/LT2668184T/lt unknown
- 2012-01-27 HU HUE12701884A patent/HUE037153T2/hu unknown
- 2012-01-27 KR KR1020187031264A patent/KR20180122028A/ko not_active Application Discontinuation
- 2012-01-27 CA CA2823824A patent/CA2823824C/fr active Active
- 2012-01-27 RU RU2013138624/04A patent/RU2600976C2/ru active
- 2012-01-27 PT PT127018844T patent/PT2668184T/pt unknown
- 2012-01-27 MX MX2013008673A patent/MX356411B/es active IP Right Grant
- 2012-01-27 KR KR1020137022330A patent/KR101923751B1/ko active IP Right Grant
- 2012-01-27 AR ARP120100272A patent/AR084935A1/es active IP Right Grant
- 2012-01-27 PL PL12701884T patent/PL2668184T3/pl unknown
- 2012-01-27 EP EP12701884.4A patent/EP2668184B1/fr active Active
- 2012-01-27 AU AU2012210467A patent/AU2012210467B2/en active Active
- 2012-01-27 DK DK12701884.4T patent/DK2668184T3/en active
- 2012-01-27 SI SI201231273T patent/SI2668184T1/en unknown
- 2012-01-27 RS RS20180418A patent/RS57101B1/sr unknown
- 2012-01-27 TR TR2018/02944T patent/TR201802944T4/tr unknown
- 2012-01-27 MA MA36177A patent/MA34903B1/fr unknown
- 2012-01-27 JP JP2013550886A patent/JP5931926B2/ja active Active
- 2012-01-27 US US13/823,658 patent/US20130172360A1/en not_active Abandoned
- 2012-01-27 ES ES12701884.4T patent/ES2661695T3/es active Active
- 2012-01-27 UA UAA201310425A patent/UA109698C2/ru unknown
- 2012-01-27 WO PCT/EP2012/051283 patent/WO2012101239A1/fr active Application Filing
- 2012-11-27 US US13/686,334 patent/US8883821B2/en active Active
-
2013
- 2013-07-11 TN TNP2013000293A patent/TN2013000293A1/fr unknown
- 2013-07-16 IL IL227496A patent/IL227496B/en active IP Right Grant
- 2013-12-24 HK HK13114261.8A patent/HK1186737A1/xx unknown
-
2018
- 2018-02-26 IL IL257748A patent/IL257748B/en active IP Right Grant
- 2018-03-26 CY CY20181100338T patent/CY1120088T1/el unknown
- 2018-03-29 HR HRP20180524TT patent/HRP20180524T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2970967B1 (fr) | Derives de type azaindazole ou diazaindazole comme medicament | |
ZA201406968B (en) | Soft chewable pharmaceutical product | |
DK3501558T3 (da) | Flydbare vævsprodukter | |
BR112014012778A2 (pt) | embalagem de cateter | |
DK3143998T3 (da) | Inhalerbart lægemiddel omfattende tiotropium | |
HK1205146A1 (en) | Pharmaceutical formulation | |
BR112014015885A8 (pt) | preparação farmacêutica | |
PL2720707T3 (pl) | Przeciwzapalne produkty farmaceutyczne | |
EP2671578A4 (fr) | Médicament prophylactique ou thérapeutique pour neuropathie périphérique provoquée par un agent anticancéreux | |
HK1205683A1 (en) | Pharmaceutical formulation having improved stability | |
DK3473255T3 (da) | Farmaceutisk formulering omfattende ciclesonid | |
BR302012006318S1 (pt) | Configuração aplicada em vaporizador de produtos fluidos | |
EP2668185A4 (fr) | Composition pharmaceutique comprenant des dérivés de pyridone | |
BR112012021455A2 (pt) | formulação farmacêutica ou nutracêutica. | |
BR302012006320S1 (pt) | Configuração aplicada em vaporizador de produtos fluidos | |
GB201222679D0 (en) | Pharmaceutical combination products | |
AU2012265231A1 (en) | Nasal pharmaceutical formulation | |
GB201206384D0 (en) | Antibacterial drug derivatives | |
IT1399867B1 (it) | Inserto illustrativo per medicinali. | |
GB201206385D0 (en) | Antibacterial drug derivatives | |
GB201206383D0 (en) | Antibacterial drug derivatives | |
PT2833866T (pt) | Produtos farmacêuticos mastigáveis moles | |
UA21305S (uk) | Упаковка для медичних виробів | |
AU2011900419A0 (en) | Cosmetic or pharmaceutical formulation | |
UA22858S (uk) | Упакування для лікарського засобу «віферон» |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |